Supreme Court To Hear Medtronic Pre-emption Case, Despite Irregularities
This article was originally published in The Gray Sheet
Executive Summary
The U.S. Supreme Court reaffirmed Oct. 1 that it will hear a case against Medtronic this session that could settle the long-standing issue of whether FDA premarket approval protects device manufacturers from liability in patient lawsuits